Redefining the role of HIV viral load monitoring.

In 1996, the Food and Drug Administration (FDA) approved labeling of the Roche Amplicor HIV-1 Monitor assay for use in determining the prognosis of patients with HIV infection. An analysis of the claim that the device can be used in conjunction with clinical presentation and other laboratory markers of disease progression for the clinical management of HIV… CONTINUE READING